Benchmark (BMK) full year 2021 results presentation - November 2021

Benchmark's CEO, Trond Williksen and CFO, Septima Maguire present the full year results for the period ended 30th September 2021. Trond Williksen, CEO 00:17 – Introduction 00:52 – Highlights of the period 04:21 – Performance highlights 06:48 – Operational highlights Septima Maguire, CFO 13:16 – Financial review 15:44 – Segmental highlights 23:07 – Cash flow 24:29 – Looking forward Trond Williksen, CEO 26:22 – Strategy 28:23 – ‘One Benchmark’ opportunities 29:33 – Current trading & Outlook 31:07 – Investment case 31:36 – Closing remarks Benchmark Holdings plc is engaged in the provision of aquaculture health, genetics and nutrition. The Company’s segments include genetics, advanced nutrition and health. The Company develops products that helps fish and shrimp to improve their sustainability and profitability by improving yield, quality, and by reducing mortality. The Company’s products include high genetic quality ova for salmon, shrimp and tilapia, and breeding, program, specialist feeds for early stage shrimp and fish; probiotics, biocides and medicines.